Structure-based identification of new orally bioavailable BRD9-PROTACs for treating acute myelocytic leukemia

Post time 2024-3-28 21:04:28

journal：European Journal of Medicinal Chemistry

Authors：Jingyu Zhang; Haiting Duan; Renzhao Gui; Mingfei Wu; Liteng Shen; Yuheng Jin; Ao Pang; Xiaoli Yu; Shenxin Zeng; Bo Zhang; Nengming Lin; Wenhai Huang; Yuwei Wang; Xiaojun Yao; Jia Li; Xiaowu Dong; Yubo Zhou; Jinxin Che

Published date：2023-12-

DOI：10.1016/j.ejmech.2023.115872

PDF link：https://www.sciencedirect.com/sc ... 223523423008395/pdf

Article link：http://dx.doi.org/10.1016/j.ejmech.2023.115872

Article Source：Elsevier BV。

Remark：

Post time 2024-3-28 21:04:29

: This post has been completed
Completed attachments will be deleted within 24 hours.

[Elsevier] Structure-based identification of new orally bioavailable BRD9-PROTACs for treating acute myelocytic leukemia

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[Elsevier] Structure-based identification of new orally bioavailable BRD9-PROTACs for treating acute myelocytic leukemia Copy

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[Elsevier] Structure-based identification of new orally bioavailable BRD9-PROTACs for treating acute myelocytic leukemia